Longview Ventures
Investor profile
Venture capital
Deals
2
distinct rounds
Companies
2
backed
Active span
2024–2025
2 yrs
Total round €
€137M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- +ND Capital1
- 4see Ventures1
- Alexandria Venture Investments1
- Apollo Health Ventures1
- Athos Capital1
- Bernina BioInvest1
- Dawn Biopharma1
- Earlybird Venture Capital1
- Eli lilly and company1
- Export and Investment Fund of Denmark (EIFO)1
- LifeLink Ventures1
- Novo Holdings1
- Pictet1
- Schroders Capital1
- Sofinnova Partners1
- SR One1
- Versant Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Antag Therapeutics | Denmark | 1 | €80M |
| haya therapeutics | Switzerland | 1 | €57M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Antag Therapeutics | Series A | €80M | 2024-12 |
| haya therapeutics | Series A | €57M | 2025-05 |